Xavier Monroy

696 total citations
17 papers, 580 citations indexed

About

Xavier Monroy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Xavier Monroy has authored 17 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Xavier Monroy's work include Pharmacological Receptor Mechanisms and Effects (9 papers), Receptor Mechanisms and Signaling (7 papers) and Neuropeptides and Animal Physiology (7 papers). Xavier Monroy is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (9 papers), Receptor Mechanisms and Signaling (7 papers) and Neuropeptides and Animal Physiology (7 papers). Xavier Monroy collaborates with scholars based in Spain and Norway. Xavier Monroy's co-authors include Xavier Guitart, Xavier Codony, Albert Dordal, Alfonso Lavado, Patricia Cozar, Raquel Pérez-Gómez, Lluı́s Montoliu, Francina Langa, Estela Giménez and Victoria Tovar and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Xavier Monroy

17 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Monroy Spain 8 493 293 121 55 47 17 580
Jianfeng Mei United States 10 538 1.1× 339 1.2× 47 0.4× 24 0.4× 71 1.5× 11 589
Sarah L. Huszar United States 10 239 0.5× 179 0.6× 52 0.4× 73 1.3× 27 0.6× 12 400
Bastian Frehland Germany 13 347 0.7× 265 0.9× 182 1.5× 37 0.7× 10 0.2× 26 465
Julian A. Schreiber Germany 11 208 0.4× 165 0.6× 70 0.6× 22 0.4× 30 0.6× 36 322
Buddy Pouw United States 12 501 1.0× 352 1.2× 64 0.5× 46 0.8× 15 0.3× 16 591
Rebecca A. Roof United States 11 390 0.8× 184 0.6× 76 0.6× 37 0.7× 15 0.3× 19 510
John T. Lazzaro United States 10 275 0.6× 226 0.8× 153 1.3× 35 0.6× 16 0.3× 15 435
Ria Wouters Belgium 7 201 0.4× 208 0.7× 86 0.7× 23 0.4× 40 0.9× 8 396
Daniela C. G. Bertarelli Germany 7 337 0.7× 229 0.8× 116 1.0× 15 0.3× 18 0.4× 7 497
Dorothée Möller Germany 15 577 1.2× 276 0.9× 55 0.5× 27 0.5× 65 1.4× 17 741

Countries citing papers authored by Xavier Monroy

Since Specialization
Citations

This map shows the geographic impact of Xavier Monroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Monroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Monroy more than expected).

Fields of papers citing papers by Xavier Monroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Monroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Monroy. The network helps show where Xavier Monroy may publish in the future.

Co-authorship network of co-authors of Xavier Monroy

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Monroy. A scholar is included among the top collaborators of Xavier Monroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Monroy. Xavier Monroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brea, José, Diana López, Mario Barro, et al.. (2024). In vitro models for neuropathic pain phenotypic screening in brain therapeutics. Pharmacological Research. 202. 107111–107111. 1 indexed citations
2.
Christmann, Ute, José Luis Dı́az, Rosalía Pascual, et al.. (2023). Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties. Journal of Medicinal Chemistry. 66(17). 12499–12519. 7 indexed citations
3.
Brea, José, Eduardo Domínguez, Catarina Allegue, et al.. (2022). Identification of Sodium Transients Through NaV1.5 Channels as Regulators of Differentiation in Immortalized Dorsal Root Ganglia Neurons. Frontiers in Cellular Neuroscience. 16. 816325–816325. 3 indexed citations
4.
Fernández‐Pastor, Begoña, Mónica Garcı́a, Javier Burgueño, et al.. (2022). Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids. Acta Pharmaceutica Sinica B. 13(1). 82–99. 4 indexed citations
5.
Brea, José, et al.. (2021). Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening. PLoS ONE. 16(3). e0248139–e0248139. 4 indexed citations
6.
Brea, José, Eduardo Domínguez, Catarina Allegue, et al.. (2021). Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain. ACS Chemical Neuroscience. 12(14). 2619–2628. 3 indexed citations
7.
Garcı́a, Mónica, Mónica Alonso, Adriana Port, et al.. (2019). 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. Journal of Medicinal Chemistry. 63(5). 2434–2454. 29 indexed citations
8.
Terni, Beatrice, Javier Burgueño, Xavier Monroy, et al.. (2019). Outside‐in regulation of the readily releasable pool of synaptic vesicles by α2δ‐1. The FASEB Journal. 34(1). 1362–1377. 6 indexed citations
9.
Brea, José, et al.. (2018). A New Model of Sensorial Neuron-Like Cells for HTS of Novel Analgesics for Neuropathic Pain. SLAS DISCOVERY. 24(2). 158–168. 11 indexed citations
10.
Dı́az, José Luis, Jordi Corbera, Ana Montero, et al.. (2017). Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 1: 4-acylamino derivatives. MedChemComm. 8(6). 1235–1245. 4 indexed citations
11.
Burgueño, Javier, et al.. (2017). A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses. Scientific Reports. 7(1). 15389–15389. 21 indexed citations
12.
Dı́az, José Luis, Ute Christmann, Ariadna Fernández, et al.. (2015). Synthesis and Structure–Activity Relationship Study of a New Series of Selective σ1Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles. Journal of Medicinal Chemistry. 58(5). 2441–2451. 34 indexed citations
13.
Guitart, Xavier, Xavier Codony, & Xavier Monroy. (2004). Sigma receptors: biology and therapeutic potential. Psychopharmacology. 174(3). 301–19. 201 indexed citations
14.
Holenz, Jörg, Ramon Mercè, José Luis Dı́az, et al.. (2004). Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6Receptor Ligands. Journal of Medicinal Chemistry. 48(6). 1781–1795. 78 indexed citations
15.
Langa, Francina, Xavier Codony, Victoria Tovar, et al.. (2003). Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice. European Journal of Neuroscience. 18(8). 2188–2196. 162 indexed citations
16.
Monroy, Xavier, et al.. (2001). Decrease of adenylyl cyclase activity and expression by a sigma1 receptor ligand and putative atypical antipsychotic. Neuroreport. 12(9). 1989–1992. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026